MICHAEL JAMES OVERMAN to Quinazolines
This is a "connection" page, showing publications MICHAEL JAMES OVERMAN has written about Quinazolines.
Connection Strength
0.108
-
Phase II study of saracatinib (AZD0530) in patients with previously treated metastatic colorectal cancer. Invest New Drugs. 2015 Aug; 33(4):977-84.
Score: 0.089
-
The addition of erlotinib to gemcitabine and cisplatin does not appear to improve median survival in metastatic pancreatic cancer. Invest New Drugs. 2013 Oct; 31(5):1375-83.
Score: 0.019